BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kakaei F, Beheshtirouy S, Nejatollahi SM, Zarrintan S, Mafi MR. Surgical treatment of gallbladder carcinoma: a critical review. Updates Surg 2015;67:339-51. [PMID: 26563387 DOI: 10.1007/s13304-015-0328-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Wang P, Zhou C, Li D, Zhang D, Wei L, Deng Y. circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways. Oncol Lett 2021;22:563. [PMID: 34113391 DOI: 10.3892/ol.2021.12824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget 2017;8:3104-10. [PMID: 27902971 DOI: 10.18632/oncotarget.13621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Xu B, Chen Z, Zhang J, Chang J, Zhao W, Dong Z, Zhi X, Li T. Prognostic Value of Peripheral Whole Blood Cell Counts Derived Indexes in Gallbladder Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:707742. [PMID: 34262875 DOI: 10.3389/fonc.2021.707742] [Reference Citation Analysis]
4 Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng M, Zhou D, Tang Z, Wang JD, Quan Z. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Mol Cancer 2019;18:145. [PMID: 31623628 DOI: 10.1186/s12943-019-1078-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 17.3] [Reference Citation Analysis]
5 Zhang X, Gui X, Zhang Y, Liu Q, Zhao L, Gao J, Ji J, Zhang Y. A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer. Front Oncol 2022;12:858639. [PMID: 35433420 DOI: 10.3389/fonc.2022.858639] [Reference Citation Analysis]
6 Deng Y, Zhang F, Yu X, Huo CL, Sun ZG, Wang S. Prognostic Value Of Preoperative Systemic Inflammatory Biomarkers In Patients With Gallbladder Cancer And The Establishment Of A Nomogram. Cancer Manag Res 2019;11:9025-35. [PMID: 31695494 DOI: 10.2147/CMAR.S218119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Sun L, Ke X, Wang D, Yin H, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival. J Cancer 2021;12:4172-82. [PMID: 34093818 DOI: 10.7150/jca.49242] [Reference Citation Analysis]
8 Zhao X, Wang Y, Yu Q, Yu P, Zheng Q, Yang X, Gao D. Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review). Int J Mol Med 2020;46:1611-32. [PMID: 33000182 DOI: 10.3892/ijmm.2020.4731] [Reference Citation Analysis]
9 Gong K, Gong ZJ, Lu PX, Ni XL, Shen S, Liu H, Wang JW, Zhang DX, Liu HB, Suo T. PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma. Biochem Biophys Res Commun 2019;516:983-90. [PMID: 31272718 DOI: 10.1016/j.bbrc.2019.06.121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
10 Liu Z, Yan C, Xiao Y, Zhang W, Wang L, Li Q, Cai W. Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma. Oncol Lett 2021;21:234. [PMID: 33613723 DOI: 10.3892/ol.2021.12495] [Reference Citation Analysis]
11 Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K, Yao H, Yao J, Wang H, Liang X, Hu Z. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Oncotarget 2017;8:47052-63. [PMID: 28423362 DOI: 10.18632/oncotarget.16789] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
12 Wang J, Yao Y, Ming Y, Shen S, Wu N, Liu J, Liu H, Suo T, Pan H, Zhang D, Ding K, Liu H. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. Sci Rep. 2016;6:28833. [PMID: 27349455 DOI: 10.1038/srep28833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu Z, Zhu G, Jiang X, Zhao Y, Zeng H, Jing J, Ma X. Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning. Front Oncol 2020;10:604288. [PMID: 33330105 DOI: 10.3389/fonc.2020.604288] [Reference Citation Analysis]
14 Wang S, Liu C, Liu X, He Y, Shen D, Luo Q, Dong Y, Dong H, Pang Z. Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines. Tumour Biol 2017;39:1010428317718192. [PMID: 29034777 DOI: 10.1177/1010428317718192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
15 Wietsma MFT, Molloy C, Bhimani N, de Savornin Lohman EAJ, Gill AJ, Andrici J, Samra J, de Reuver PR, Hugh TJ. Gallbladder carcinoma outcomes in an Australian tertiary referral hospital. ANZ J Surg 2021;91:603-8. [PMID: 33604992 DOI: 10.1111/ans.16663] [Reference Citation Analysis]
16 Li X, Liu Y, Wang Y, Ruan C, Wang H, Liang X, Sun Y, Hu Z. The influence of marital status on survival of gallbladder cancer patients: a population-based study. Sci Rep 2017;7:5322. [PMID: 28706207 DOI: 10.1038/s41598-017-05545-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
17 Kong W, Zhang L, An R, Yang M, Wang H. Diagnostic Value of Serum D-Dimer for Detection of Gallbladder Carcinoma. Cancer Manag Res 2021;13:2549-56. [PMID: 33762846 DOI: 10.2147/CMAR.S272116] [Reference Citation Analysis]